Vanguard Global Advisers’s Journey Medical DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$31.8K Hold
4,642
– – ﹤0.01% 3218
2026
Q2
$32.9K Hold
4,642
– – ﹤0.01% 3202
2026
Q1
$21.8K Buy
+4,642
New +$36K ﹤0.01% 3284

Other funds holding DERM

Vanguard Global Advisers's DERM Position: Q3 2026 in Review

Vanguard Global Advisers held its Journey Medical (DERM) position steady in Q3 2026 at 4,642 shares worth $31.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3218.

Vanguard Global Advisers first reported a position in DERM in Q1 2026 and has held it in 3 quarters since. The position peaked at $32.9K in Q2 2026. 74 funds tracked by Wall St. Rank hold DERM as of Q3 2026.

  • Vanguard Global Advisers held 4,642 shares of Journey Medical worth $31.8K as of Q3 2026.
  • Vanguard Global Advisers left its Journey Medical share count unchanged in Q3 2026.
  • Journey Medical made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3218 holding.
  • Vanguard Global Advisers first reported a position in Journey Medical in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Journey Medical position peaked at $32.9K in Q2 2026.
  • 74 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.